S. Pedersen (Kolding, Denmark), S. Saglani (London, United Kingdom)
Transparency in evidence-based pediatric asthma guidelines: GRADE and the other considerations
N. Boluyt, B. Rottier, E. Vrijlandt, J. de Jongste (Amsterdam, Groningen, Rotterdam, Netherlands)
|   |
A systematic review of underlying reasons for barriers to asthma management in ethnic minority children
D. Bird, G. Perkins, L. Culley, J. Grigg, M. Johnson, N. Johal, L. Manikam, M. McFeeters, N. Robertson, J. Wilson, M. Lakhanpaul (Leicester, London, Stoke on Trent, United Kingdom)
| |
Low agreement between current and long-term asthma control in children: The PACMAN cohort study
E. Koster, J. Raaijmakers, S. Vijverberg, L. Koenderman, D. Postma, G. Koppelman, C. van der Ent, A. H. Maitland-van der Zee (Utrecht, Groningen, Netherlands)
| |
Poor adherence to inhaled corticosteroids in childhood asthma: Don‘t blame (only) the patient
T. Klok, A. Kaptein, E. Duiverman, P. Brand (Zwolle, Leiden, Groningen, Netherlands)
| |
Lack of behavioural problems in preschool children using inhaled corticosteroids with high adherence
W. Quak, T. Klok, P. Brand (Zwolle, Netherlands)
| |
How much inhaled steroid is sufficient? Assessing the relationship between adherence rate to beclomethasone dipropionate and the level of asthma control
P. Camargos, N. Jentzsch (Divinópolis, Belo Horizonte, Brazil)
| |
Fluticasone propionate/formoterol fumarate (FLUT/FORM) combination therapy has comparable efficacy to fluticasone propionate/salmeterol xinafoate (FLUT/SAL) in paediatric patients with asthma
T. McIver, A. Emeryk, R. Klink, B. Schwab (Cambridge, United Kingdom; Lublin, Poland; Laon, France; Limburg (Lahn), Germany)
| |
Long-term treatment with fluticasone propionate/formoterol fumarate (FLUT/FORM) combination therapy is well-tolerated and provides sustained effectiveness in paediatric patients with asthma
T. McIver, A. Emeryk, R. Klink, B. Schwab (Cambridge, United Kingdom; Lublin, Poland; Laon, France; Limburg (Lahn), Germany)
| |
Salivary cortisol for assessment of hypothalamic-pituitary-adrenal (HPA) axis function in asthmatic children on inhaled corticosteroids (ICS)
L. Tsartsali, M. Papadopoulos, E. Lagona, G. Chrousos, K. Priftis (Athens, Greece)
| |
The oral corticosteroid sparing effect of omalizumab in patients with severe chronic asthma: Is there a difference when you become 12 years old?
S. Moss, M. Mckean, D. Spencer (Newcastle upon Tyne, United Kingdom)
| |
Safety and efficacy of omalizumab in children with allergic asthma
J. Pitts, S. Sheikh, K. McCoy (Columbus, United States Of America)
| |
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children
W. Dong, X. Zhou, J. Hong (Shanghai, China)
| |
Did inappropriate delivery systems hamper therapeutic efficacy of di-sodium-cromo-glycate (DSCG)? Time for a reappraisal
M. Keller, O. Denk, A. Bucholski, M. Knoch (Graefelfing, Germany)
| |
Designing a holding chamber mask using anthropometric data and CAD-simulation
A. Söderholm Labre, S. Merk, F. Kummer, K. Behrenbruch (Starnberg, Westensee, Germany)
| |
Breath-by-breath delivered dose comparison from three anti-static valved holding chambers with facemasks under simulated pediatric breathing conditions
W. Hsu, D. von Hollen, Z. Xu, T. Bai, K. Nikander, R. Dalby (Baltimore, Parsippany, United States Of America)
| |